Maridebart Biosimilar - Research Grade

Human

GIPRï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P48546

Blue ice

GIPR is an incretin receptor that integrates nutrient and metabolic signaling, increasingly central to obesity and metabolic-disease research. Designed as an unconjugated, non-therapeutic analog of maridebart, this human anti-GIPR recombinant monoclonal (IgG1, kappa) is intended for research use only (RUO). It is produced to a low-endotoxin standard that supports in vivo use and supplied in scalable milligram to gram quantities to meet the needs of bulk and high-throughput laboratories. Researchers can apply it as a consistent control and functional reagent in receptor-binding and signaling assays, in vitro screening, and preclinical in vivo metabolic disease models.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks